Digital biomarkers are revolutionizing the way healthcare professionals and researchers monitor, diagnose, and treat diseases. Enabled by digital technologies, these biomarkers provide objective, quantifiable physiological and behavioral data collected through connected devices such as smartphones, wearables, and sensors. Unlike traditional biomarkers, which rely on laboratory tests or imaging, digital biomarkers enable continuous, real-world monitoring, offering… Continue reading Digital Biomarkers: Transforming Healthcare Through Continuous and Real-World Monitoring
Tag: AI
AI-Driven Protocol Digitalization: Reshaping Clinical Research
The integration of artificial intelligence (AI) into clinical trial protocol digitalization is transforming key aspects of drug development. By applying analytical and predictive AI, there is the potential to design smarter, more efficient protocols, ensuring greater precision in endpoint definition, improved compliance, and reduced trial timelines. This article explores some of the applications AI… Continue reading AI-Driven Protocol Digitalization: Reshaping Clinical Research
Harnessing the Power of AI: Revolutionizing Signal Detection in Drug Safety
Traditional methods of signal detection rely on manual review and analysis of large amounts of data, often resulting in delays and missed opportunities for early detection of signals. On the other hand, artificial intelligence (AI) has the potential to enhance activities in pharmacovigilance leading to a much earlier detection of potential safety concerns. But how… Continue reading Harnessing the Power of AI: Revolutionizing Signal Detection in Drug Safety